South Africa
· Delayed Price · Currency is ZAR Dis-Chem Pharmacies Statistics
Total Valuation
Dis-Chem Pharmacies has a market cap or net worth of ZAR 31.46 billion. The enterprise value is 36.01 billion.
| Market Cap | 31.46B |
| Enterprise Value | 36.01B |
Important Dates
The next estimated earnings date is Friday, January 24, 2025.
| Earnings Date | Jan 24, 2025 |
| Ex-Dividend Date | Nov 20, 2024 |
Share Statistics
Dis-Chem Pharmacies has 857.35 million shares outstanding. The number of shares has decreased by -0.16% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 857.35M |
| Shares Change (YoY) | -0.16% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 8.18% |
| Owned by Institutions (%) | 50.64% |
| Float | 527.09M |
Valuation Ratios
The trailing PE ratio is 29.66 and the forward PE ratio is 26.92. Dis-Chem Pharmacies's PEG ratio is 2.24.
| PE Ratio | 29.66 |
| Forward PE | 26.92 |
| PS Ratio | 0.83 |
| PB Ratio | 6.48 |
| P/TBV Ratio | 9.05 |
| P/FCF Ratio | 37.33 |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.24 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.97, with an EV/FCF ratio of 42.74.
| EV / Earnings | 33.93 |
| EV / Sales | 0.95 |
| EV / EBITDA | 11.97 |
| EV / EBIT | 18.24 |
| EV / FCF | 42.74 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 1.11.
| Current Ratio | 1.19 |
| Quick Ratio | 0.40 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | 1.81 |
| Debt / FCF | 6.38 |
| Interest Coverage | 3.77 |
Financial Efficiency
Return on equity (ROE) is 24.28% and return on invested capital (ROIC) is 12.45%.
| Return on Equity (ROE) | 24.28% |
| Return on Assets (ROA) | 6.95% |
| Return on Capital (ROIC) | 12.45% |
| Revenue Per Employee | 1.90M |
| Profits Per Employee | 53,063 |
| Employee Count | 20,000 |
| Asset Turnover | 2.18 |
| Inventory Turnover | 4.08 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.35% in the last 52 weeks. The beta is 0.20, so Dis-Chem Pharmacies's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +25.35% |
| 50-Day Moving Average | 3,737.54 |
| 200-Day Moving Average | 3,493.11 |
| Relative Strength Index (RSI) | 43.95 |
| Average Volume (20 Days) | 1,276,217 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dis-Chem Pharmacies had revenue of ZAR 37.99 billion and earned 1.06 billion in profits. Earnings per share was 1.24.
| Revenue | 37.99B |
| Gross Profit | 8.61B |
| Operating Income | 1.93B |
| Pretax Income | 1.50B |
| Net Income | 1.06B |
| EBITDA | 2.35B |
| EBIT | 1.93B |
| Earnings Per Share (EPS) | 1.24 |
Balance Sheet
The company has 824.41 million in cash and 5.37 billion in debt, giving a net cash position of -4.55 billion or -5.31 per share.
| Cash & Cash Equivalents | 824.41M |
| Total Debt | 5.37B |
| Net Cash | -4.55B |
| Net Cash Per Share | -5.31 |
| Equity (Book Value) | 4.86B |
| Book Value Per Share | 5.66 |
| Working Capital | 1.81B |
Cash Flow
In the last 12 months, operating cash flow was 1.92 billion and capital expenditures -1.08 billion, giving a free cash flow of 842.56 million.
| Operating Cash Flow | 1.92B |
| Capital Expenditures | -1.08B |
| Free Cash Flow | 842.56M |
| FCF Per Share | 0.98 |
Margins
Gross margin is 22.66%, with operating and profit margins of 5.09% and 2.79%.
| Gross Margin | 22.66% |
| Operating Margin | 5.09% |
| Pretax Margin | 3.94% |
| Profit Margin | 2.79% |
| EBITDA Margin | 6.20% |
| EBIT Margin | 5.09% |
| FCF Margin | 2.22% |
Dividends & Yields
This stock pays an annual dividend of 0.49, which amounts to a dividend yield of 1.35%.
| Dividend Per Share | 0.49 |
| Dividend Yield | 1.35% |
| Dividend Growth (YoY) | 18.66% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 42.26% |
| Buyback Yield | 0.16% |
| Shareholder Yield | 1.51% |
| Earnings Yield | 3.37% |
| FCF Yield | 2.68% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Dis-Chem Pharmacies has an Altman Z-Score of 3.99.
| Altman Z-Score | 3.99 |
| Piotroski F-Score | n/a |